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Methods
Forty-one clinical samples were struck onto Mueller Hinton
Agar (MHA) plates and separated by colony morphology onto
plates containing Gentamycin, Polymyxin B, Carbenicillin, and
Ticarcillin. Colony types showing growth in the presence of three
or more of the preliminary antibiotics were then tested for relative
resistance using the Kirby Bauer Disk infusion test. In this test,
resistant strains were struck in a lawn and had eight disks
containing increasing concentrations of antibiotic placed on the
agar surface. The zones of clearing around each disk after
incubation at 37℃ for 24 hours were measured to determine
relative resistance. Isolates displaying high levels of resistance to
multiple antibiotics were frozen into stocks for further quantitative
testing. Freezer stocks of eleven highly resistant colony types
were then tested against the previously used antibiotics as well as
Oxacillin, Ciprofloxacin, Erythromycin, Vancomycin, and
Methicillin using the Minimum Inhibitory Concentration and
Minimum Bactericidal Concentration tests. From these tests,
quantitative resistance data was deduced. These isolates had their
DNA extracted, duplicated in Polymerase Chain reactions, and
sequenced using the Sanger Sequencing method. These results
were analyzed using NCBI Basic Local Assignment Search Tool
(BLAST) to identify the unknown isolates to the genus level.
Conclusions
• Multiple pathogens have the capability 
of resisting multiple different 
antibiotic therapies
• A greater number of CF isolates may 
have multidrug resistance than 
previous studies suggest
• CF isolates may have more resistance 
to a greater variety of antibiotics than 
originally predicted
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Introduction
Cystic Fibrosis (CF) is an autosomal recessive disease caused
by a mutated Cystic Fibrosis Transmembrane Conductance
Regulator (CFTR) gene located on chromosome 7 [1]. The CFTR
protein is a chloride ion channel. When the CFTR gene is
mutated, it causes the protein to be absent or lose function, which
leads to dehydration in the lung’s airways and also traps mucus
inside the lungs [2]. These conditions in the lung generate a
perfect environment for bacterial colonization by multiple
different species [3]. Chronic bacterial colonization and
development of antibiotic resistance are serious concerns for CF
patients. However, many recent studies looking at the complexity
of these infections have suggested that many different types of
bacteria persist in the CF lung and acquire antibiotic resistance
through various mechanisms which significantly hinders
treatment options and drastically impacts patient mortality [4].
The diverse bacterial populations are recovered from the sputa
using biochemical selective media, catalogued, and cryogenically
stored. The goal is to isolate, test against various antibiotics, and
sequence general sputa from cystic fibrous patients in order to
compare their sequences and resistance capabilities to wild type
strains.
Results
Figure 1. Kirby-Bauer Disk 
Infusion Photos
Table 1: MIC Results* (Reported in mg/mL) 
Figure 3. Visual MBC Result Future Directions
• Continue sequencing and identifying 
prevalent pathogens in the CF lung
• Continue a random sampling technique 
to further identify highly resistant 
isolates
• Collect and compare genomic data to 
determine differences in wild type and 
clinical strains
• Collaborate in development of better 
clinical diagnostic testing to identify and 
treat mixed culture infections
Figure 2: Differences in Methodology: MIC vs. MBC
Table 2: Quantitative MBC Results* (Reported in mg/mL)
ID Number PM G TC CB ER OX CIP V M
3614A 0.469 5.0 >5.0 1.875 >0.10 >2.5 1.75 <0.039 2.5
3614C #17 0.234 0.938 >5.0 >5.0 >0.10 >2.5 1.75 >5.0 1.875
3614C #21 >1.875 5.0 >5.0 >5.0 >0.10 >2.5 1.75 >5.0 2.5
5814F #1 0.469 1.875 1.25 1.25 >0.10 0.313 0.438 <0.039 1.25
5814F #5 0.351 0.938 1.25 2.5 >0.10 0.963 0.438 <0.039 >2.5
5814B 0.469 >5.0 >5.0 >5.0 >0.10 0.469 0.656 >5.0 >2.5
5813E 0.234 1.875 2.5 >5.0 >0.10 0.625 0.438 >5.0 >2.5
61214B 0.234 <0.04 1.875 0.938 >0.10 0.313 0.027 <0.039 >2.5
6514A 0.703 1.875 2.5 >5.0 >0.10 0.313 1.75 <0.039 1.25
7314A 0.176 <0.04 0.938 0.938 >0.10 0.234 0.656 0.098 0.328
8714C 0.938 0.234 0.313 1.25 >0.10 1.25 0.656 <0.039 <0.020
ID # PM G TC CB ER OX CIP V M
3614A 0.469 >5.0 >5.0 >5.0 >0.10 >2.5 >1.75 <0.039 >2.5
3614C #17 0.117 0.938 >5.0 >5.0 >0.10 >2.5 >1.75 >5.0 >2.5
3614C #21 >1.875 5.0 >5.0 >5.0 >0.10 >2.5 1.75 >5.0 >2.5
5814F #1 0.938 1.875 3.125 1.25 >0.10 0.313 0.656 <0.039 1.875
5814F #5 0.586 1.25 1.875 2.5 >0.10 1.25 0.438 <0.039 >2.5
5814B 0.469 >5.0 >5.0 >5.0 >0.10 0.469 >1.75 >5.0 >2.5
5813E 0.234 5.0 >5.0 >5.0 >0.10 >2.5 >1.75 >5.0 >2.5
61214B 0.234 <0.04 3.75 0.938 >0.10 0.469 0.027 <0.039 >2.5
6514A 0.938 1.875 2.5 >5.0 >0.10 0.313 1.75 <0.039 1.25
7314A 0.469 <0.04 0.938 0.938 >0.10 0.234 0.656 0.098 0.328
8714C 0.938 0.234 0.313 1.25 >0.10 1.25 >1.75 <0.039 0.059
*PM = Polymyxin B, G = Gentamycin, TC = Ticarcillin, CB = Carbenicillin, 
ER = Erythromycin, OX = Oxacillin, CIP = Ciprofloxacin, V = Vancomycin, 
M = Methicillin
ID Number Genus ID
3614A Enterococcus
3614C #17 Trichosporon
3614C #21 Trichosporon
5814F #1 Staphylococcus
5814F #5 Staphylococcus
5814B Candida
5813E Candida
61214B Staphylococcus
6514A Staphylococcus
7314A Staphylococcus
8714C Staphylococcus
Table 3: Isolate Genus
Identification
